Re-engineering Nutrition: How Rem3dy Health Is Scaling Personalisation from the West Midlands

From concept to global export, the West Midlands gave Rem3dy Health the ecosystem to scale fast.

Rem3dy Health is a Birmingham-based technology developer focused on developing additive and advanced manufacturing technology driven by AI-enabled algorithms to personalise both preventive and curative health.

As personalisation reshapes global industries, in nutritional manufacturing, production remains rigid in scale over specificity.

With an increasing demand for healthcare solutions to be tailored to consumers’ lifestyles, the question facing the Life Sciences sector is no longer whether personalisation improves outcomes, but whether manufacturing systems can support it.

For Rem3dy Health CEO and Founder Melissa Snover, the drive for greater personalisation in health and nutrition was personal. Prior to Rem3dy Health, Melissa had developed what became the world’s first vegan, allergen-free gummy candy – growing the brand to over 35,000 stores in three years. The experience enabled her to partner with one of the world’s largest gummy manufacturers, providing her with significant operational and commercial insight whilst exposing her to the structural inefficiencies within traditional manufacturing.

I walked away from that experience with a ton of learning, but also a huge amount of frustration around the restriction and the lack of agility in mainstream manufacturing.

 

New product development cycles take on average 2 to 3 years in mainstream manufacturing and even the biggest brands in the world can’t do seasonal innovation on a profitable basis. It meant that the consumer was having to choose from a limited set of options.

 

– Melissa Snover, Founder, Rem3dy Health

With global manufacturing optimised for mass efficiency, Rem3dy Health saw an opportunity to rebuild the manufacturing model itself. In re-engineering nutritional manufacturing through emerging technologies, Rem3dy would be able to drive personalisation and significantly reduce the time between product innovation cycles.

The whole premise is that personalisation in nutrition equals better outcomes.

 

So, when we went to market, we really tried to drive that point home. Every individual person is living a unique life, has unique health and wants different things. Up until now, manufacturing did not allow for them to access that.

 

– Melissa Snover

For Rem3dy Health to address this strategic challenge, it needed a robust innovation ecosystem and supply chain that could enable tech-led production on a global scale.

Rem3dy Health quickly identified the West Midlands, the UK’s industrial and innovation heartland, as its strategic base from which to scale.

Attracted by the region’s academic R&D strengths, dynamic start-up ecosystem, and competitive cost environment, the company selected Birmingham’s vibrant creative quarter, Digbeth, as its entry point. Doing so placed the firm alongside a wealth of high-growth tech and digital start-ups, whilst providing direct access a talent pool of 96,000 workers employed within the region’s Data Driven Healthcare sector.

The West Midlands has the most robust and impressive combination of academia, private industry, public institutions and physical hubs, which encourage collaboration and innovation.

– Melissa Snover

Rem3dy Health landed in the region with support from the West Midlands Growth Company (WMGC).

Through strategic introductions and valuable network access to the region’s industrial and academic ecosystem, WMGC’s support enabled Rem3dy Health to form early-stage relationships with key regional stakeholders. This strong regional foundation supported Rem3dy’s development of its patented, in-house production capabilities, which now underpin the company’s long-term growth trajectory.

As the partnership between the WMGC and Rem3dy Health grew, the WMGC also provided valuable PR support, guidance on export pathways and R&D relief programmes — helping to strengthen Rem3dy’s expanding profile within the region’s ecosystem and accelerating its route to international markets through its participation in the Grow Global Export Programme.

We started working with the West Midlands Growth Company in January of 2020. We have participated in multiple events like the WMGC’s It Starts Here campaign launch, South by Southwest and the Midlands takeover at London Tech Week, where, alongside the WMGC, we have been able to promote our business, raise awareness and network with investment opportunities.

– Melissa Snover

Supported by partnerships with the WMGC and the West Midlands’ tech ecosystem, Rem3dy Health has scaled into a global exporter of personalised nutritional supplements under its consumer brand Nourished.

Pioneered through patented advanced manufacturing technology developed in-house, the company’s innovation breakthroughs include twenty-nine patents spanning hardware engineering, materials science, and processes.

Together, these breakthroughs have enabled the Rem3dy Health to industrialise personalised nutrition at scale. Not only increasing the precision of production, but establishing a fully traceable, data-driven manufacturing model that has transformed how nutritional supplements are formulated, manufactured, quality-controlled, and distributed globally.

The firm is currently installing an innovative AI-enabled camera system designed to automate quality control across its high-speed production line. The system strengthens Rem3dy’s traceability and output capabilities – showcasing the real-world application of AI, advanced manufacturing, and life sciences within the West Midlands.

Not only are we continuing to innovate. But we are also developing new products, new concepts and finding new ways for our base technology to be expanded into different product categories to support more people in different ways.

 

Without the innovations that we have developed, we would never be where we are now.

 

– Melissa Snover

In recent years, Rem3dy’s innovation-led approach to growth has enabled the firm to significantly expand its advanced manufacturing capabilities in the West Midlands, creating approximately 70 skilled roles across production, engineering, and technical functions.

This was followed by the consolidation of its operations into its larger Sandwell production site in 2023.

The transition from its former headquarters in Digbeth marked a new chapter for Rem3dy Health. Expanding in the West Midlands, this strategic shift allows Rem3dy’s cross-disciplinary functions to integrate and collaborate more effectively. Resulting in an agile, solution-driven culture, which is accelerating the firm’s innovation cycles.

The West Midlands has always been a proving ground for big ideas, helping shape the global economy for over two centuries through innovative technologies.

For MedTech or Life Science firms who are seeking to transform global health outcomes through advanced manufacturing, AI, and data-driven discovery, the West Midlands stands as one of UK’s top locations for clinical trials, offering un-matched access to one of Europe’s youngest and most diverse populations. Enabling innovators to unlock deeper clinical data to drive insights and rapid strategic decision-making.

This momentum is further fuelled by a combination of region’s next-generation talent, R&D infrastructure, and unmatched connectivity, which is powering the international reach of organisations headquartered in the West Midlands. Offering investors standout speed-to-market opportunities through partnerships with world-renowned academic institutions and centres of excellence.

The close-knit network of academic innovation hubs like the Birmingham Health Innovation Campus and STEAMhouse provide opportunities to address global challenges through access to world-leading R&D facilities.

Rem3dy Health’s strong partnership with Birmingham City University exemplifies the region’s commitment to fostering meaningful collaboration between industry and academia.

Through engagement with STEAMhouse, the company has gained valuable R&D and commercial insight, supporting product development and innovation strategy. Likewise, Rem3dy Health has recruited directly from the university’s graduate talent pool, strengthening its technical capability while retaining high-value skills within the West Midlands ecosystem.

We value our current collaborations with the regional academic institutions and hubs like STEAMHouse. They are incredibly positive and they continue to grow on an annual basis. That continues to really excite me and exceed expectations.

 

– Melissa Snover

As Rem3dy Health continues to scale at pace, the company is progressing new product categories including longevity formulations targeting brain health along with longer-term applications in personalised medicine.

Multiple clinical trials in partnership with regional universities are in development, with the potential to generate breakthrough research outcomes that strengthen the firm’s product pipeline and commercial credibility across the globe.

The WGMC remains committed to partnering with Rem3dy Health as it continues to scale and expand in the region where breakthroughs begin and legacies are made.

We are the home of the industrial manufacturing industry in the UK. That is the heritage of the West Midlands, and that still exists.

 

So being able to disrupt manufacturing with innovative advancements and then combine that with medical science, nutritional science, formulary science and AI, shows all those different areas of expertise in the region coming together.

 

– Melissa Snover